Published • loading... • Updated
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner - Emergent BioSolutions (NYSE:EBS)
Summary by Benzinga
1 Articles
1 Articles
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner - Emergent BioSolutions (NYSE:EBS)
GAITHERSBURG, Md., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced it has secured new purchase orders from an international government partner for a multi-product supply agreement valued at $29 million (USD). The orders span several product offerings within Emergent's medical countermeasures (MCM) business, including countermeasures for smallpox, anthrax and botulism threats, and reflects the increasing p…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium